ENTX
$3.43
Entera Bio
$.02
.59%
ENTX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.11)
Revenue:  $0.07 Mil
Wednesday
Feb 9
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, November 10, 2021

What do you expect when ENTX reports earnings?
Beat
Meet
Miss

Where is ENTX's stock price going from here?
Up
Flat
Down
Stock chart of ENTX
Analysts
Summary of analysts' recommendations for ENTX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.